SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ries LAG,Melbert D,Krapcho M, et al. SEER Cancer Statistics Review, 1975‒2004. Bethesda, MD: National Cancer Institute; 2007.
  • 2
    Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000; 15: 603630.
  • 3
    Mulhern RK,Fairclough D,Ochs J. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol. 1991; 9: 13481356.
  • 4
    Butler RW,Haser JK. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev. 2006; 12: 184191.
  • 5
    Campbell LK,Scaduto M,Sharp W, et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2007; 49: 6573.
  • 6
    Nathan PC,Patel SK,Dilley K, et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med. 2007; 161: 798806.
  • 7
    Achenbach TM,Rescorla LA. Manual for the ASEBA School-Age Forms and Profiles. Burlington, VT: ASEBA; 2001.
  • 8
    Reynolds CR,Kamphaus RW. Behavior Assessment System for Children-Manual. Circle Pine, MN: American Guidance Service, Inc; 1992.
  • 9
    Derogatis LR. Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual. Minneapolis, MN: NCS Pearson; 2000.
  • 10
    Butcher JN,Dahlstrom WG,Graham JR,Tellegen AM,Kaemmer B. MMPI-2: Manual for Administration and Scoring. Minneapolis: University of Minnesota Press; 1989.
  • 11
    Buysse DJ,Reynolds CFIII,Monk TH,Berman SR,Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28: 193213.
  • 12
    Varni JW,Seid M,Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999; 37: 126139.
  • 13
    Kreutzer JS,Seel RT,Marwitz JH. Neurobehavioral Functioning Inventory. San Antonio, TX: The Psychological Corporation; 1999.
  • 14
    Williams JM. Cognitive Behavior Rating Scales Research Edition. Lutz, FL: Psychological Assessment Resources, Inc; 1987.
  • 15
    Grace J,Malloy PF. Frontal Systems Behavior Scale. Lutz, FL: Psychological Assessment Resources, Inc; 2001.
  • 16
    Roth RM,Isquith PK,Gioia GA. Behavior Rating Inventory of Executive Function—Adult Version. Lutz, FL: Psychological Assessment Resources, Inc; 2005.
  • 17
    Shallice T,Burgess P. Higher-order cognitive impairments and frontal lobe lesions in man. In: LevinHS,BentonAL, eds. Frontal Lobe Function and Dysfunction. New York, NY: Oxford University Press; 1991.
  • 18
    Lezak MD,Howieson DB,Loring DW. Neuropsychological Assessment. 4th ed. New York, NY: Oxford University Press; 2004; 125138.
  • 19
    Gioia GA,Isquith PK,Guy SC,Kenworthy L. Behavior Rating Inventory of Executive Function. Odessa, FL: Psychological Assessment Resources, Inc; 2000.
  • 20
    Mulhern RK,Armstrong FD,Thompson SJ. Function-specific neuropsychological assessment. Med Pediatr Oncol. 1998;( suppl 1): 3440.
  • 21
    Kennedy RE,Livingston L,Riddick A,Marwitz JH,Kreutzer JS,Zasler ND. Evaluation of the Neurobehavioral Functioning Inventory as a depression screening tool after traumatic brain injury. J Head Trauma Rehabil. 2005; 20: 512526.
  • 22
    Aaronson NK,Ahmedzai S,Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365376.
  • 23
    Coates A,Porzsolt F,Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer. 1997; 33: 10251030.
  • 24
    Robison LL,Mertens AC,Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002; 38: 229239.
  • 25
    Zill N,Peterson J. Behavior Problems Index. Washington, DC: Child Trends Inc; 1986.
  • 26
    Achenbach TM. Manual for the Child Behavior Checklist. Burlington: University of Vermont, Department of Psychiatry; 1991.
  • 27
    Schultz KA,Ness KK,Whitton J, et al. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2007; 25: 36493656.
  • 28
    Recklitis CJ,Parsons SK,Shih MC,Mertens A,Robison LL,Zeltzer L. Factor structure of the brief symptom inventory-18 in adult survivors of childhood cancer: results from the childhood cancer survivor study. Psychol Assess. 2006; 18: 2232.
  • 29
    Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951; 16: 297334.
  • 30
    Biederman J,Petty CR,Fried R, et al. Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatr Scand. 2007; 116: 129136.
  • 31
    Friedman NP,Haberstick BC,Willcutt EG, et al. Greater attention problems during childhood predict poorer executive functioning in late adolescence. Psychol Sci. 2007; 18: 893900.
    Direct Link:
  • 32
    Mulhern RK,Merchant TE,Gajjar A,Reddick WE,Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004; 5: 399408.
  • 33
    Spiegler BJ,Kennedy K,Maze R, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol. 2006; 24: 38583864.
  • 34
    Waber DP,De Moor C,Forbes PW, et al. The NIH MRI study of normal brain development: performance of a population based sample of healthy children aged 6 to 18 years on a neuropsychological battery. J Int Neuropsychol Soc. 2007; 13: 729746.
  • 35
    Kim CH,Lee SA,Yoo HJ,Kang JK,Lee JK. Executive performance on the Wisconsin Card Sorting Test in mesial temporal lobe epilepsy. Eur Neurol. 2007; 57: 3946.
  • 36
    Drane DL,Lee GP,Cech H, et al. Structured cueing on a semantic fluency task differentiates patients with temporal versus frontal lobe seizure onset. Epilepsy Behav. 2006; 9: 339344.
  • 37
    Locke DE,Berry DT,Fakhoury TA,Schmitt FA. Relationship of indicators of neuropathology, psychopathology, and effort to neuropsychological results in patients with epilepsy or psychogenic non-epileptic seizures. J Clin Exp Neuropsychol. 2006; 28: 325340.
  • 38
    McDonald CR,Delis DC,Norman MA,Tecoma ES,Iragui-Madozi VI. Is impairment in set-shifting specific to frontal-lobe dysfunction? Evidence from patients with frontal-lobe or temporal-lobe epilepsy. J Int Neuropsychol Soc. 2005; 11: 477481.
  • 39
    McDonald CR,Delis DC,Norman MA,Wetter SR,Tecoma ES,Iragui VJ. Response inhibition and set shifting in patients with frontal lobe epilepsy or temporal lobe epilepsy. Epilepsy Behav. 2005; 7: 438446.
  • 40
    Nys GM,van Zandvoort MJ,van der Worp HB,Kappelle LJ,de Haan EH. Neuropsychological and neuroanatomical correlates of perseverative responses in subacute stroke. Brain. 2006; 129(pt 8): 21482157.
  • 41
    Ziemus B,Baumann O,Luerding R, et al. Impaired working-memory after cerebellar infarcts paralleled by changes in BOLD signal of a cortico-cerebellar circuit. Neuropsychologia. 2007; 45: 20162024.
  • 42
    Stephens S,Kenny RA,Rowan E, et al. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia. J Am Geriatr Soc. 2005; 53: 103107.
  • 43
    Komoda T,Drews T,Sakuraba S,Kubo M,Hetzer R. Executive cognitive dysfunction without stroke after long-term mechanical circulatory support. ASAIO J. 2005; 51: 764768.
  • 44
    Vicario A,Martinez CD,Baretto D,Diaz Casale A,Nicolosi L. Hypertension and cognitive decline: impact on executive function. J Clin Hypertens (Greenwich). 2005; 7: 598604.
  • 45
    Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci. 2004; 226: 2529.
  • 46
    Anderson V,Godber T,Smibert E,Ekert H. Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: an analysis of risk factors. Pediatr Rehabil. 1997; 1: 6376.
  • 47
    Maddrey AM,Bergeron JA,Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol. 2005; 72: 245253.
  • 48
    Floyd FJ,Widaman KF. Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess. 1995; 7: 286299.
  • 49
    Brennan P,Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ. 1992; 304: 14911494.
  • 50
    Thompson WD,Walter SD. A reappraisal of the kappa coefficient. J Clin Epidemiol. 1988; 41: 949958.
  • 51
    Christopher G,MacDonald J. The impact of clinical depression on working memory. Cognit Neuropsychiatry. 2005; 10: 379399.
  • 52
    DeLuca AK,Lenze EJ,Mulsant BH, et al. Comorbid anxiety disorder in late life depression: association with memory decline over 4 years. Int J Geriatr Psychiatry. 2005; 20: 848854.
  • 53
    Frais AT. Depression and the causal role of specific memory system degenerations: link may be supported by reported therapeutic benefits of Omega 3 fatty acids. Med Hypotheses. 2007; 69: 6769.
  • 54
    Watts SE,Weems CF. Associations among selective attention, memory bias, cognitive errors and symptoms of anxiety in youth. J Abnorm Child Psychol. 2006; 34: 841852.
  • 55
    Reddick WE,Glass JO,Helton KJ, et al. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol. 2005; 26: 12631269.
  • 56
    Waber DP,Carpentieri SC,Klar N, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol. 2000; 22: 206213.